New COVID-19 booster shots put to the test in small human trial

NCT ID NCT07605520

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two experimental COVID-19 booster vaccines alongside two already-approved ones in 48 healthy adults aged 18 to 65. Participants receive one injection and are monitored for side effects and antibody levels over 48 weeks. The goal is to see if the new vaccines are safe and produce a strong immune response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULTS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CIC 1417 - Hôpital Cochin
RECRUITING

Paris, France

Contact Email: •••••@•••••
Centre Hospitalier Universitaire Vaudois (CHUV)
RECRUITING

Lausanne, Switzerland

Contact Email: •••••@•••••
Hôpital Henri Mondor
RECRUITING

Créteil, France

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.